SEC Filings

SEC Filings

Filing date	Description	Form	View
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000193.pdf 0001214659-18-000193.rtf 0001214659-18-000193.xls
Dec 29, 2017	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0001193125-17-382679.pdf 0001193125-17-382679.rtf 0001193125-17-382679.xls
Dec 22, 2017	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-17-074865.pdf 0001104659-17-074865.rtf 0001104659-17-074865.xls
Dec 21, 2017	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-17-000173.pdf 0001235802-17-000173.rtf
Dec 15, 2017	Amendment to a previously filed 8-K	8-K/A	View HTML 0001104659-17-073617.pdf 0001104659-17-073617.rtf 0001104659-17-073617.xls
Nov 21, 2017	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001047469-17-007229.pdf 0001047469-17-007229.rtf 0001047469-17-007229.xls
Nov 17, 2017	EFFECT	EFFECT	View HTML 9999999995-17-003014.pdf 9999999995-17-003014.rtf 9999999995-17-003014.xls
Nov 17, 2017	CORRESP	CORRESP	View HTML 0001628280-17-011660.pdf 0001628280-17-011660.rtf 0001628280-17-011660.xls
Nov 14, 2017	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001558370-17-008932.pdf 0001558370-17-008932.rtf 0001558370-17-008932.xls EX-101.INS - EX-101.INS
Nov 14, 2017	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-17-068500.pdf 0001104659-17-068500.rtf 0001104659-17-068500.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE